Gene Symbol | Gene ID | Gene Info |
---|---|---|
Id4
|
ENSMUSG00000021379.1 | inhibitor of DNA binding 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_48260396_48261208 | Id4 | 426 | 0.704804 | -0.06 | 6.9e-01 | Click! |
chr13_48261341_48262187 | Id4 | 536 | 0.446923 | -0.00 | 9.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_65961618_65962124 | 70.20 |
Ankrd12 |
ankyrin repeat domain 12 |
10521 |
0.14 |
chr17_52601056_52601789 | 17.49 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr18_72949026_72949703 | 15.52 |
Gm31908 |
predicted gene, 31908 |
28274 |
0.23 |
chr10_81364518_81366962 | 15.43 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr6_17796921_17797464 | 14.24 |
Gm26738 |
predicted gene, 26738 |
37993 |
0.12 |
chr1_3671269_3672324 | 14.14 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr10_100520287_100520558 | 13.66 |
Cep290 |
centrosomal protein 290 |
11696 |
0.14 |
chr18_12947284_12947832 | 11.83 |
Osbpl1a |
oxysterol binding protein-like 1A |
5717 |
0.19 |
chr14_4110111_4111235 | 11.48 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr6_37642704_37643180 | 11.45 |
Ybx1-ps2 |
Y box protein 1, pseudogene 2 |
44253 |
0.17 |
chr8_12873206_12874084 | 11.36 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr8_23934635_23934786 | 11.27 |
Zmat4 |
zinc finger, matrin type 4 |
5657 |
0.32 |
chr10_87813103_87813541 | 11.25 |
Igf1os |
insulin-like growth factor 1, opposite strand |
15040 |
0.22 |
chr5_32713265_32714499 | 11.15 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr14_7244047_7245236 | 10.93 |
Gm5456 |
predicted gene 5456 |
3199 |
0.18 |
chr9_102193238_102193748 | 10.69 |
Gm37945 |
predicted gene, 37945 |
20755 |
0.17 |
chr14_6037512_6038662 | 10.27 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr18_78454680_78455309 | 9.73 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
21884 |
0.23 |
chr8_12915219_12915955 | 9.43 |
Gm15351 |
predicted gene 15351 |
32 |
0.8 |
chr14_96518648_96518966 | 9.42 |
Klhl1 |
kelch-like 1 |
295 |
0.93 |
chr5_133718570_133718754 | 9.28 |
Gm36667 |
predicted gene, 36667 |
120256 |
0.06 |
chr7_18942456_18942756 | 9.15 |
Nova2 |
NOVA alternative splicing regulator 2 |
16718 |
0.08 |
chr8_4217407_4217800 | 9.10 |
Prr36 |
proline rich 36 |
144 |
0.9 |
chr14_14349938_14350878 | 8.96 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr3_138906418_138907063 | 8.84 |
Tspan5 |
tetraspanin 5 |
46247 |
0.14 |
chr6_82939285_82939948 | 8.80 |
Sema4f |
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain |
71 |
0.94 |
chr14_60554058_60554987 | 8.72 |
Gm47810 |
predicted gene, 47810 |
42380 |
0.15 |
chr5_112237414_112237869 | 8.63 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
8246 |
0.12 |
chr10_79533095_79534301 | 8.55 |
Plpp2 |
phospholipid phosphatase 2 |
59 |
0.95 |
chr4_56128107_56128471 | 8.51 |
Gm12520 |
predicted gene 12520 |
34651 |
0.21 |
chr12_102731704_102731855 | 8.51 |
Gm28373 |
predicted gene 28373 |
4446 |
0.09 |
chr17_52602043_52602770 | 8.44 |
Gm27217 |
predicted gene 27217 |
254 |
0.55 |
chr3_41564545_41565250 | 8.39 |
Jade1 |
jade family PHD finger 1 |
1 |
0.96 |
chr1_85916954_85917154 | 8.27 |
Itm2c |
integral membrane protein 2C |
10893 |
0.12 |
chr3_34503986_34504142 | 8.26 |
Gm29135 |
predicted gene 29135 |
21857 |
0.16 |
chr12_27064915_27065316 | 8.22 |
Gm9866 |
predicted gene 9866 |
49880 |
0.18 |
chr7_139075496_139075906 | 8.17 |
Jakmip3 |
janus kinase and microtubule interacting protein 3 |
1731 |
0.34 |
chr11_35856326_35856649 | 8.10 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
2933 |
0.25 |
chr7_40900527_40901069 | 8.07 |
A230077H06Rik |
RIKEN cDNA A230077H06 gene |
139 |
0.87 |
chr1_109982807_109983363 | 7.96 |
Cdh7 |
cadherin 7, type 2 |
79 |
0.99 |
chrX_143518258_143518409 | 7.90 |
Pak3 |
p21 (RAC1) activated kinase 3 |
258 |
0.95 |
chr9_106126758_106127335 | 7.85 |
Gm29208 |
predicted gene 29208 |
8 |
0.95 |
chr5_52516049_52516436 | 7.85 |
Gm43685 |
predicted gene 43685 |
22589 |
0.13 |
chr18_5979242_5979943 | 7.80 |
Gm34804 |
predicted gene, 34804 |
34409 |
0.16 |
chr7_87584510_87584710 | 7.77 |
Grm5 |
glutamate receptor, metabotropic 5 |
212 |
0.96 |
chr4_133055540_133056727 | 7.76 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
10116 |
0.19 |
chr10_81559146_81561402 | 7.74 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr11_3132475_3133419 | 7.70 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
3060 |
0.17 |
chr18_54631497_54631648 | 7.67 |
9330117O12Rik |
RIKEN cDNA 9330117O12 gene |
19828 |
0.25 |
chr19_6976181_6976733 | 7.65 |
Ppp1r14b |
protein phosphatase 1, regulatory inhibitor subunit 14B |
8 |
0.48 |
chr8_35933319_35934071 | 7.63 |
Gm22030 |
predicted gene, 22030 |
43883 |
0.13 |
chr7_76185076_76185361 | 7.63 |
Agbl1 |
ATP/GTP binding protein-like 1 |
44669 |
0.17 |
chr7_96168957_96169147 | 7.62 |
Tenm4 |
teneurin transmembrane protein 4 |
2194 |
0.37 |
chr1_124045941_124046349 | 7.53 |
Dpp10 |
dipeptidylpeptidase 10 |
586 |
0.86 |
chrX_143543266_143543620 | 7.52 |
Pak3 |
p21 (RAC1) activated kinase 3 |
24745 |
0.25 |
chr12_27566321_27566542 | 7.48 |
Gm4166 |
predicted gene 4166 |
31770 |
0.22 |
chr15_85498298_85498479 | 7.42 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
4839 |
0.21 |
chr1_81077432_81077601 | 7.42 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
67 |
0.99 |
chr1_66388570_66388940 | 7.41 |
Map2 |
microtubule-associated protein 2 |
1744 |
0.39 |
chr8_13916690_13916913 | 7.36 |
Fbxo25 |
F-box protein 25 |
8998 |
0.12 |
chr4_118261785_118262467 | 7.33 |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
25681 |
0.15 |
chr16_21665050_21665238 | 7.33 |
2510009E07Rik |
RIKEN cDNA 2510009E07 gene |
28087 |
0.17 |
chr8_83389953_83390240 | 7.32 |
Clgn |
calmegin |
218 |
0.91 |
chr9_92930513_92930898 | 7.28 |
Gm28054 |
predicted gene 28054 |
34873 |
0.17 |
chr7_84409236_84410328 | 7.25 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr19_40307541_40307870 | 7.24 |
Sorbs1 |
sorbin and SH3 domain containing 1 |
4043 |
0.19 |
chr9_45663652_45664379 | 7.23 |
Dscaml1 |
DS cell adhesion molecule like 1 |
8822 |
0.19 |
chrX_100767870_100768490 | 7.15 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
185 |
0.93 |
chr1_5233165_5233347 | 7.13 |
Gm7182 |
predicted gene 7182 |
44081 |
0.16 |
chr7_93062174_93062609 | 7.12 |
Fam181b |
family with sequence similarity 181, member B |
17474 |
0.16 |
chr5_26991582_26992107 | 7.08 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr1_153703440_153704005 | 7.07 |
5530400K19Rik |
RIKEN cDNA 5530400K19 gene |
10932 |
0.11 |
chr5_98376482_98376803 | 7.05 |
E030032P16Rik |
RIKEN cDNA E030032P16 gene |
30248 |
0.17 |
chr10_81464661_81465630 | 7.04 |
Gm16105 |
predicted gene 16105 |
3986 |
0.08 |
chr1_5022831_5023607 | 6.98 |
Rgs20 |
regulator of G-protein signaling 20 |
3680 |
0.21 |
chr9_74366046_74366203 | 6.96 |
Nr1h2-ps |
nuclear receptor subfamily 1, group H, member 2, pseudogene |
1061 |
0.56 |
chr7_91208818_91209022 | 6.95 |
Gm24552 |
predicted gene, 24552 |
34075 |
0.14 |
chr13_119408014_119408896 | 6.92 |
Nnt |
nicotinamide nucleotide transhydrogenase |
497 |
0.78 |
chr3_34659889_34660091 | 6.92 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
3954 |
0.13 |
chr4_140070081_140070517 | 6.90 |
Gm13027 |
predicted gene 13027 |
61578 |
0.1 |
chr8_4492910_4494136 | 6.89 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr9_118255960_118256455 | 6.89 |
Gm17399 |
predicted gene, 17399 |
105976 |
0.06 |
chr5_42523203_42523390 | 6.86 |
Gm7181 |
predicted gene 7181 |
22882 |
0.28 |
chr8_112269835_112269986 | 6.83 |
Gm3635 |
predicted gene 3635 |
32944 |
0.22 |
chr2_71244927_71245170 | 6.82 |
Dync1i2 |
dynein cytoplasmic 1 intermediate chain 2 |
10249 |
0.21 |
chr1_104768332_104769548 | 6.81 |
Cdh20 |
cadherin 20 |
411 |
0.86 |
chr5_9344694_9344865 | 6.81 |
Gm15733 |
predicted gene 15733 |
8980 |
0.2 |
chr8_70120713_70121043 | 6.81 |
Ncan |
neurocan |
5 |
0.94 |
chr2_126552518_126552835 | 6.80 |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
269 |
0.92 |
chr10_108701744_108702064 | 6.79 |
Gm5136 |
predicted gene 5136 |
1744 |
0.46 |
chr5_112225580_112225794 | 6.77 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
2954 |
0.16 |
chr15_64117558_64118367 | 6.73 |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
4808 |
0.22 |
chr16_28752897_28753619 | 6.71 |
Fgf12 |
fibroblast growth factor 12 |
190 |
0.97 |
chr8_100500075_100500292 | 6.71 |
Gm45296 |
predicted gene 45296 |
61425 |
0.15 |
chr9_13699411_13699759 | 6.70 |
Gm47105 |
predicted gene, 47105 |
27857 |
0.15 |
chr2_143545112_143545712 | 6.69 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
565 |
0.54 |
chr3_135887426_135887611 | 6.69 |
Slc39a8 |
solute carrier family 39 (metal ion transporter), member 8 |
3358 |
0.17 |
chr4_78211506_78212633 | 6.68 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
108 |
0.5 |
chr6_88976654_88976847 | 6.67 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
26067 |
0.14 |
chr2_127444443_127444898 | 6.63 |
Fahd2a |
fumarylacetoacetate hydrolase domain containing 2A |
105 |
0.96 |
chr14_24578363_24578849 | 6.63 |
4930542C16Rik |
RIKEN cDNA 4930542C16 gene |
38698 |
0.14 |
chr4_39344371_39344735 | 6.62 |
Gm23607 |
predicted gene, 23607 |
49090 |
0.15 |
chr14_5388691_5389629 | 6.57 |
Gm3500 |
predicted gene 3500 |
111 |
0.95 |
chr1_126573759_126573924 | 6.56 |
Nckap5 |
NCK-associated protein 5 |
80914 |
0.11 |
chr2_62808909_62809197 | 6.56 |
Gm13569 |
predicted gene 13569 |
134 |
0.97 |
chr3_108401377_108402718 | 6.56 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
542 |
0.59 |
chrX_42361986_42362271 | 6.55 |
Gm14619 |
predicted gene 14619 |
14616 |
0.27 |
chr1_189187702_189188139 | 6.55 |
2900042K21Rik |
RIKEN cDNA 2900042K21 gene |
23093 |
0.18 |
chr4_10974713_10974905 | 6.54 |
Rps11-ps3 |
ribosomal protein S11, pseudogene 3 |
28201 |
0.14 |
chr6_126514813_126515020 | 6.48 |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
20496 |
0.18 |
chr15_39196745_39196980 | 6.45 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
1399 |
0.38 |
chr3_105530220_105530411 | 6.45 |
Gm43847 |
predicted gene 43847 |
27408 |
0.18 |
chr14_118422286_118422688 | 6.44 |
Gm5672 |
predicted gene 5672 |
46293 |
0.11 |
chr2_179481023_179481235 | 6.41 |
Cdh4 |
cadherin 4 |
36896 |
0.19 |
chr3_88222179_88222410 | 6.41 |
Gm3764 |
predicted gene 3764 |
370 |
0.69 |
chr10_75892899_75893716 | 6.41 |
Derl3 |
Der1-like domain family, member 3 |
106 |
0.92 |
chr10_81230756_81230930 | 6.39 |
Atcay |
ataxia, cerebellar, Cayman type |
10 |
0.93 |
chr11_32161571_32162227 | 6.39 |
Gm12109 |
predicted gene 12109 |
23106 |
0.12 |
chr2_163919125_163919282 | 6.39 |
Rims4 |
regulating synaptic membrane exocytosis 4 |
520 |
0.79 |
chr9_15774617_15774937 | 6.38 |
Slc36a4 |
solute carrier family 36 (proton/amino acid symporter), member 4 |
47889 |
0.12 |
chr10_13117108_13117586 | 6.37 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
983 |
0.59 |
chr12_71601536_71601687 | 6.34 |
9630002D21Rik |
RIKEN cDNA 9630002D21 gene |
23646 |
0.21 |
chr3_10439292_10440192 | 6.34 |
Snx16 |
sorting nexin 16 |
345 |
0.89 |
chr17_13654565_13655321 | 6.32 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr14_74696794_74696945 | 6.31 |
Gm9212 |
predicted gene 9212 |
20843 |
0.19 |
chr6_113889602_113889753 | 6.31 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
1693 |
0.36 |
chr13_77878249_77878431 | 6.29 |
Pou5f2 |
POU domain class 5, transcription factor 2 |
146562 |
0.04 |
chr12_117258209_117258499 | 6.29 |
Mir153 |
microRNA 153 |
7537 |
0.29 |
chr12_27357279_27357647 | 6.29 |
Sox11 |
SRY (sex determining region Y)-box 11 |
14889 |
0.28 |
chr2_13175406_13175888 | 6.29 |
Gm37780 |
predicted gene, 37780 |
12024 |
0.2 |
chrX_11099815_11099966 | 6.28 |
Gm14485 |
predicted gene 14485 |
78883 |
0.09 |
chr10_86769945_86770113 | 6.28 |
Gm49358 |
predicted gene, 49358 |
6057 |
0.11 |
chr4_101508891_101509449 | 6.28 |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
1140 |
0.54 |
chr6_15408521_15408744 | 6.27 |
Gm25470 |
predicted gene, 25470 |
3651 |
0.32 |
chr15_10421870_10422041 | 6.24 |
Dnajc21 |
DnaJ heat shock protein family (Hsp40) member C21 |
28037 |
0.15 |
chr7_74844609_74844760 | 6.21 |
Gm44903 |
predicted gene 44903 |
6714 |
0.2 |
chr14_13284898_13285304 | 6.21 |
Synpr |
synaptoporin |
260 |
0.69 |
chr13_84449556_84449849 | 6.18 |
Gm26927 |
predicted gene, 26927 |
109589 |
0.06 |
chr5_15985978_15986202 | 6.17 |
Gm43000 |
predicted gene 43000 |
11749 |
0.19 |
chr10_74922677_74923156 | 6.17 |
Gnaz |
guanine nucleotide binding protein, alpha z subunit |
44261 |
0.14 |
chr7_75329116_75329290 | 6.16 |
Sv2b |
synaptic vesicle glycoprotein 2 b |
19941 |
0.17 |
chr5_113873626_113873992 | 6.14 |
Coro1c |
coronin, actin binding protein 1C |
839 |
0.46 |
chr4_97193294_97193445 | 6.14 |
Gm27521 |
predicted gene, 27521 |
276349 |
0.01 |
chr6_121473518_121474161 | 6.14 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
161 |
0.96 |
chr16_73107664_73107993 | 6.13 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
8840 |
0.31 |
chr1_157439951_157440671 | 6.13 |
Cryzl2 |
crystallin zeta like 2 |
18266 |
0.12 |
chr7_79493955_79494148 | 6.13 |
Mir9-3hg |
Mir9-3 host gene |
5975 |
0.1 |
chr13_97823915_97824432 | 6.09 |
Gm41031 |
predicted gene, 41031 |
1712 |
0.35 |
chr15_57733954_57734285 | 6.08 |
9330154K18Rik |
RIKEN cDNA 9330154K18 gene |
4547 |
0.23 |
chr7_49065788_49065939 | 6.07 |
Gm45207 |
predicted gene 45207 |
3282 |
0.25 |
chr5_142583912_142584249 | 6.07 |
Mmd2 |
monocyte to macrophage differentiation-associated 2 |
1212 |
0.4 |
chr15_74156883_74157046 | 6.06 |
Gm15387 |
predicted gene 15387 |
62631 |
0.12 |
chr8_64624864_64625015 | 6.06 |
Cpe |
carboxypeptidase E |
2942 |
0.32 |
chr19_14507172_14507352 | 6.05 |
Tle4 |
transducin-like enhancer of split 4 |
88277 |
0.1 |
chr15_34678263_34678977 | 6.04 |
Nipal2 |
NIPA-like domain containing 2 |
84 |
0.97 |
chr8_40634456_40635069 | 6.03 |
Mtmr7 |
myotubularin related protein 7 |
3 |
0.98 |
chr1_45925560_45926387 | 6.03 |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
364 |
0.82 |
chr11_9500619_9500781 | 6.03 |
Gm36954 |
predicted gene, 36954 |
204923 |
0.03 |
chr5_115435769_115435939 | 6.02 |
Msi1 |
musashi RNA-binding protein 1 |
356 |
0.61 |
chr3_109496606_109496769 | 6.02 |
Vav3 |
vav 3 oncogene |
1903 |
0.49 |
chr9_10904618_10904989 | 6.02 |
Cntn5 |
contactin 5 |
28 |
0.89 |
chr2_142303367_142303654 | 6.01 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
126903 |
0.06 |
chr8_4677704_4678740 | 6.01 |
Gm7461 |
predicted gene 7461 |
143 |
0.62 |
chrX_75673394_75674325 | 6.01 |
Gm15065 |
predicted gene 15065 |
31550 |
0.13 |
chr14_3048629_3049241 | 6.00 |
Gm2897 |
predicted gene 2897 |
350 |
0.83 |
chr1_84695469_84695682 | 5.99 |
Mir5126 |
microRNA 5126 |
264 |
0.66 |
chr3_83980882_83981074 | 5.98 |
Tmem131l |
transmembrane 131 like |
12750 |
0.25 |
chr10_81230482_81230696 | 5.97 |
Atcay |
ataxia, cerebellar, Cayman type |
196 |
0.83 |
chr11_71751148_71751512 | 5.97 |
Wscd1 |
WSC domain containing 1 |
46 |
0.97 |
chr7_28981963_28982879 | 5.97 |
Map4k1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
371 |
0.56 |
chr18_61692296_61692680 | 5.95 |
Gm38165 |
predicted gene, 38165 |
104 |
0.94 |
chr5_103911497_103911895 | 5.95 |
Klhl8 |
kelch-like 8 |
437 |
0.79 |
chr1_50647338_50647489 | 5.95 |
Gm20118 |
predicted gene, 20118 |
114383 |
0.07 |
chr6_39870574_39870972 | 5.95 |
Tmem178b |
transmembrane protein 178B |
688 |
0.54 |
chr13_105444197_105444941 | 5.91 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
930 |
0.71 |
chr15_7193540_7193868 | 5.91 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
29365 |
0.2 |
chr1_105843089_105843248 | 5.90 |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
23298 |
0.17 |
chr14_39473001_39473750 | 5.89 |
Nrg3 |
neuregulin 3 |
287 |
0.95 |
chr17_55445850_55446443 | 5.89 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
98 |
0.98 |
chr3_127225478_127225684 | 5.86 |
Ank2 |
ankyrin 2, brain |
266 |
0.89 |
chr2_24761902_24762681 | 5.85 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
756 |
0.65 |
chr8_117446765_117446916 | 5.83 |
Mir7077 |
microRNA 7077 |
6183 |
0.18 |
chr5_98976230_98976410 | 5.83 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
9564 |
0.25 |
chr1_42233320_42233527 | 5.82 |
Gm9915 |
predicted gene 9915 |
3696 |
0.21 |
chr7_79535477_79536145 | 5.82 |
Gm35040 |
predicted gene, 35040 |
232 |
0.85 |
chr12_112721309_112722969 | 5.81 |
Cep170b |
centrosomal protein 170B |
35 |
0.95 |
chr7_109011431_109012123 | 5.79 |
Tub |
tubby bipartite transcription factor |
952 |
0.53 |
chr3_31309752_31310443 | 5.79 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
281 |
0.81 |
chr6_114846251_114846445 | 5.78 |
Atg7 |
autophagy related 7 |
9803 |
0.19 |
chr1_35243045_35243196 | 5.77 |
Gm25096 |
predicted gene, 25096 |
64036 |
0.14 |
chr5_68705525_68705676 | 5.76 |
Gm42850 |
predicted gene 42850 |
110854 |
0.07 |
chr14_5741218_5741986 | 5.76 |
Gm3373 |
predicted gene 3373 |
25 |
0.96 |
chr11_75870033_75870230 | 5.74 |
Gm16075 |
predicted gene 16075 |
9162 |
0.19 |
chr5_15850216_15850406 | 5.73 |
Gm42453 |
predicted gene 42453 |
19936 |
0.14 |
chr7_128119231_128119382 | 5.72 |
Gm49368 |
predicted gene, 49368 |
2870 |
0.12 |
chr18_55733414_55733925 | 5.71 |
Gm26959 |
predicted gene, 26959 |
12559 |
0.26 |
chr2_51753056_51753280 | 5.70 |
Gm13490 |
predicted gene 13490 |
21159 |
0.21 |
chr16_42269692_42269901 | 5.69 |
Gap43 |
growth associated protein 43 |
6276 |
0.24 |
chr2_41675777_41675949 | 5.69 |
Lrp1b |
low density lipoprotein-related protein 1B |
113215 |
0.07 |
chr11_106020469_106020812 | 5.69 |
Kcnh6 |
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
6867 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.8 | 11.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
3.6 | 10.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
3.6 | 14.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
3.5 | 10.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.1 | 9.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.1 | 12.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
2.6 | 2.6 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
2.5 | 10.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.5 | 7.6 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.5 | 10.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.4 | 11.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.3 | 7.0 | GO:0006868 | glutamine transport(GO:0006868) |
2.3 | 7.0 | GO:0021586 | pons maturation(GO:0021586) |
2.3 | 11.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.2 | 2.2 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
2.2 | 13.3 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.2 | 6.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.2 | 2.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.2 | 8.6 | GO:0046959 | habituation(GO:0046959) |
2.1 | 6.4 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.0 | 12.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.8 | 5.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.8 | 5.4 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.8 | 5.4 | GO:0030070 | insulin processing(GO:0030070) |
1.8 | 7.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.8 | 5.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.8 | 5.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.7 | 5.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.7 | 6.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.7 | 10.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.6 | 4.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.6 | 4.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.6 | 10.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.5 | 4.6 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.5 | 3.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.5 | 4.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.5 | 12.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.5 | 3.0 | GO:1903935 | response to sodium arsenite(GO:1903935) |
1.5 | 4.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.5 | 5.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.5 | 5.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.4 | 2.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.4 | 2.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.4 | 4.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.4 | 2.7 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.4 | 5.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.4 | 4.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.4 | 10.8 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.3 | 14.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.3 | 4.0 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
1.3 | 3.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.3 | 1.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
1.3 | 2.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.3 | 6.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.3 | 3.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.3 | 5.1 | GO:1901660 | calcium ion export(GO:1901660) |
1.3 | 5.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.3 | 5.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.2 | 3.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.2 | 5.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.2 | 5.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.2 | 3.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.2 | 6.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.2 | 2.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.2 | 8.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.2 | 2.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.2 | 7.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.2 | 3.6 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.2 | 3.5 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.1 | 4.5 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.1 | 3.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.1 | 3.4 | GO:1901656 | glycoside transport(GO:1901656) |
1.1 | 3.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.1 | 16.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.1 | 19.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 4.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.1 | 2.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.1 | 4.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.1 | 4.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.0 | 5.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.0 | 8.3 | GO:0050957 | equilibrioception(GO:0050957) |
1.0 | 3.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
1.0 | 3.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.0 | 3.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 5.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.0 | 2.0 | GO:0021564 | vagus nerve development(GO:0021564) |
1.0 | 5.0 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.0 | 7.9 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
1.0 | 2.9 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.0 | 3.9 | GO:0060023 | soft palate development(GO:0060023) |
1.0 | 3.8 | GO:0032898 | neurotrophin production(GO:0032898) |
1.0 | 1.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.0 | 2.9 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.0 | 4.8 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
1.0 | 2.9 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.9 | 7.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.9 | 2.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.9 | 6.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.9 | 9.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.9 | 2.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.9 | 5.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.9 | 4.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.9 | 3.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.9 | 5.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.9 | 2.7 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.9 | 3.6 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.9 | 1.8 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.9 | 3.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.9 | 5.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.9 | 1.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.9 | 1.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.9 | 2.7 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.9 | 3.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 7.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.9 | 4.4 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.9 | 6.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.9 | 2.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 3.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.8 | 1.7 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.8 | 1.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.8 | 2.4 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.8 | 1.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 2.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.8 | 8.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.8 | 23.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.8 | 4.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.8 | 3.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.8 | 4.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.8 | 12.7 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.8 | 2.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.8 | 2.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.8 | 13.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.8 | 2.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.8 | 1.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.8 | 2.3 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.8 | 1.5 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.8 | 2.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.8 | 3.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 0.8 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.8 | 3.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.8 | 3.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.7 | 2.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.7 | 3.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.7 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 2.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.7 | 2.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.7 | 2.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.7 | 2.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.7 | 2.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.7 | 2.9 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.7 | 1.4 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.7 | 2.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.7 | 2.9 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.7 | 0.7 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.7 | 2.9 | GO:0021764 | amygdala development(GO:0021764) |
0.7 | 3.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.7 | 8.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 1.4 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.7 | 0.7 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.7 | 1.4 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.7 | 1.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.7 | 2.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.7 | 6.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.7 | 2.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.7 | 1.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.7 | 6.1 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.7 | 4.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.7 | 4.7 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.7 | 10.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.7 | 2.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.7 | 2.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.7 | 2.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.7 | 2.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.6 | 7.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 3.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 1.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 32.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 1.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.6 | 9.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 2.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 3.8 | GO:0008354 | germ cell migration(GO:0008354) |
0.6 | 2.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 1.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.6 | 1.9 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.6 | 3.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 1.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.6 | 2.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 4.4 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.6 | 0.6 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.6 | 0.6 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.6 | 9.2 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.6 | 1.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 1.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.6 | 40.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 1.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.6 | 1.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.6 | 3.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.6 | 1.8 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.6 | 1.8 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.6 | 2.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.6 | 1.8 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.6 | 2.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.6 | 2.3 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.6 | 1.7 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.6 | 1.7 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.6 | 1.2 | GO:1902564 | negative regulation of cellular extravasation(GO:0002692) negative regulation of neutrophil activation(GO:1902564) |
0.6 | 3.4 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.6 | 2.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.6 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.6 | 4.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.6 | 2.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 3.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 1.6 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.5 | 5.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.5 | 3.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.5 | 2.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.5 | 2.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.5 | 3.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.5 | 2.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 2.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 1.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.5 | 4.3 | GO:0007614 | short-term memory(GO:0007614) |
0.5 | 2.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 0.5 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
0.5 | 2.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 1.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.5 | 2.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 1.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.5 | 1.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 2.1 | GO:0036233 | glycine import(GO:0036233) |
0.5 | 4.7 | GO:0033574 | response to testosterone(GO:0033574) |
0.5 | 5.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.5 | 2.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 4.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.5 | 1.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 2.1 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 2.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.5 | 1.5 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.5 | 1.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.5 | 1.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 0.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 2.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.5 | 2.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 1.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.5 | 2.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 1.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.5 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 2.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.5 | 2.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.5 | 0.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.5 | 1.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 2.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.5 | 1.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.5 | 1.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 4.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.5 | 1.4 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 1.4 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.5 | 8.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.5 | 0.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 1.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 1.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 1.8 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.5 | 5.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.5 | 1.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 1.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.5 | 1.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.5 | 1.4 | GO:0015824 | proline transport(GO:0015824) |
0.5 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 1.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 3.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.5 | 1.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 0.9 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.5 | 1.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 0.9 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.5 | 1.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 1.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 2.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.4 | 0.9 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 0.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.4 | 2.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 1.8 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.4 | 0.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.4 | 0.4 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.4 | 0.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.4 | 1.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 3.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.4 | 4.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.4 | 2.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 10.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.4 | 2.5 | GO:0015677 | copper ion import(GO:0015677) |
0.4 | 5.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.4 | 8.4 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.4 | 3.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 1.3 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 1.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.4 | 3.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.4 | 0.8 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.4 | 2.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 3.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.4 | 1.2 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 1.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.4 | 1.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 2.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 0.4 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.4 | 5.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.4 | 1.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 1.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.4 | 1.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 1.2 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 1.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 1.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 1.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 3.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 1.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.4 | 3.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 2.7 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.4 | 2.6 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 1.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 2.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 4.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.4 | 1.5 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 1.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 2.6 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.4 | 0.7 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.4 | 4.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.4 | 1.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.5 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.4 | 1.1 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 0.7 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 1.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 0.7 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.4 | 1.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.4 | 0.7 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 2.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 5.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.4 | 1.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 2.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 1.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 2.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 1.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 1.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 1.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 2.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 1.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 2.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.3 | 1.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 1.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 0.3 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.3 | 4.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 1.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.3 | 3.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 1.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 3.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 1.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.7 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.3 | 1.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.3 | 0.3 | GO:1904995 | positive regulation of hemoglobin biosynthetic process(GO:0046985) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 1.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 0.6 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 5.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 1.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 1.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 2.9 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 0.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 2.8 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 1.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 1.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.3 | 1.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.3 | 0.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.3 | 2.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.3 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 0.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.3 | 0.9 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 1.2 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.3 | 0.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 1.5 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.3 | 6.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 1.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 2.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.3 | 0.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 1.5 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.3 | 0.6 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 0.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.3 | 2.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.3 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.6 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.3 | 1.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 0.9 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 0.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.3 | 0.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 0.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 0.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 0.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 1.4 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.3 | 0.3 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.3 | 1.4 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.3 | 0.8 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 2.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 1.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 1.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 3.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 1.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.3 | 1.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 0.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 7.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 4.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 2.7 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 0.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.3 | 0.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.5 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 5.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 1.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 1.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 0.8 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.3 | 0.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.3 | 0.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.3 | 1.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 2.8 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.3 | 1.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 1.8 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 1.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 0.8 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 1.0 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.3 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.3 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.3 | 1.0 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.2 | 2.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 3.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.5 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.2 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 0.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 1.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 1.0 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 1.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 1.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.7 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 1.7 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 1.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 1.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 1.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 1.0 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 0.7 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 2.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.5 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 0.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 1.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.5 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 10.1 | GO:0050905 | neuromuscular process(GO:0050905) |
0.2 | 0.7 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 3.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.7 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 1.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 0.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.4 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.9 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 0.7 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.7 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.9 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 4.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 0.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.2 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.2 | 0.9 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 0.2 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 1.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 7.9 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.2 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 7.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 0.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.6 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.2 | 1.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 2.3 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 0.8 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 0.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 1.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.6 | GO:0021544 | subpallium development(GO:0021544) |
0.2 | 0.8 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.2 | 1.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.2 | 1.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.4 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 1.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 1.0 | GO:0098722 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) asymmetric stem cell division(GO:0098722) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.4 | GO:0072034 | renal vesicle induction(GO:0072034) ureter morphogenesis(GO:0072197) metanephric nephron tubule formation(GO:0072289) |
0.2 | 0.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 1.7 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 0.2 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.2 | 0.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 2.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 1.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.7 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.2 | 2.1 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 1.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 0.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.7 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 0.4 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.2 | 0.4 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 0.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 0.4 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 0.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 1.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 1.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 0.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 0.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.9 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.2 | 1.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.9 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.4 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 1.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.5 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.2 | 3.5 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.2 | 0.7 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 4.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 2.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 1.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 0.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 1.0 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 1.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 0.9 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.2 | 1.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.2 | 0.5 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 0.5 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.3 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.2 | 0.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 1.7 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.2 | 0.8 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 3.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 1.5 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.2 | 0.2 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.2 | 2.4 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.2 | 0.2 | GO:0060459 | left lung development(GO:0060459) |
0.2 | 2.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.2 | GO:0010963 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.2 | 0.5 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 2.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 3.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.5 | GO:0014889 | muscle atrophy(GO:0014889) |
0.2 | 0.6 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.2 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 3.3 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.3 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 1.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 1.4 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 1.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.8 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.2 | 0.5 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 3.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.7 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.6 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 1.5 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.4 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.9 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.4 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.1 | 1.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.1 | 3.6 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.6 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.8 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.7 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 2.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 2.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 2.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 3.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.1 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.1 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 4.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 1.6 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.6 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 1.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.7 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.6 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 1.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 1.5 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.1 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 1.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 1.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 1.3 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.1 | 0.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.6 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 1.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 1.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.4 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.1 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.4 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 2.1 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.1 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.3 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.9 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.7 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 1.3 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 1.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 2.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.8 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.4 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.3 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.4 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 1.2 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 1.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.9 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 1.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.3 | GO:0022615 | protein import into peroxisome matrix, docking(GO:0016560) protein to membrane docking(GO:0022615) |
0.1 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.8 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.1 | 0.1 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.1 | 2.7 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.1 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.4 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.1 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.5 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 1.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.9 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.2 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.5 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.2 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of chromosome segregation(GO:0051985) |
0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.2 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.1 | 1.1 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.1 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 0.1 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.1 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 1.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 1.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.1 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.7 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.4 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.6 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.2 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.5 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 2.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.4 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.1 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.1 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.1 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.0 | 0.0 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.1 | GO:0003157 | endocardium development(GO:0003157) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.8 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.5 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.1 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.7 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 1.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.2 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.0 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.0 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.3 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 1.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.2 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.0 | 0.0 | GO:0090193 | positive regulation of glomerulus development(GO:0090193) |
0.0 | 0.0 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.2 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 1.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.1 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.0 | 0.0 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.0 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.0 | GO:0044531 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.0 | 0.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.2 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.2 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.0 | 0.0 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.0 | 0.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.0 | GO:0072141 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.1 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 13.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.0 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.4 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.9 | 5.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.7 | 6.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.7 | 6.7 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.6 | 8.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.4 | 5.8 | GO:0044308 | axonal spine(GO:0044308) |
1.4 | 5.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.4 | 1.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.4 | 8.4 | GO:0002139 | stereocilia coupling link(GO:0002139) |
1.3 | 2.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.3 | 12.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 10.2 | GO:0043083 | synaptic cleft(GO:0043083) |
1.3 | 13.8 | GO:0043194 | axon initial segment(GO:0043194) |
1.2 | 2.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.2 | 8.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.2 | 4.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.1 | 5.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.1 | 3.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.1 | 18.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.0 | 5.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.0 | 3.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.0 | 3.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 2.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.9 | 14.8 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 2.7 | GO:0036396 | MIS complex(GO:0036396) |
0.9 | 2.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.9 | 13.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.9 | 4.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.9 | 1.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.8 | 8.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.7 | 2.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.7 | 5.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 12.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 2.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 9.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.7 | 2.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 4.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 2.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.7 | 4.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.7 | 3.3 | GO:0097433 | dense body(GO:0097433) |
0.6 | 1.9 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 4.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 4.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 1.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 5.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.6 | 10.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 15.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 6.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.6 | 17.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 4.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.6 | 1.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.6 | 1.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 2.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.6 | 13.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 4.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.6 | 1.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.6 | 3.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.5 | 77.9 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.5 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 6.9 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 1.0 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.5 | 2.6 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 9.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 6.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.5 | 3.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 2.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.5 | 6.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 3.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.5 | 4.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 5.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 28.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 1.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 1.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 2.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 5.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.5 | 2.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 0.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 3.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 9.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 1.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 0.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 1.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 0.9 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 1.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 19.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 2.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.4 | 1.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.4 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 39.0 | GO:0097060 | synaptic membrane(GO:0097060) |
0.4 | 1.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.3 | 4.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 13.6 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 12.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 2.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 10.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 4.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 3.4 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 2.1 | GO:0000801 | central element(GO:0000801) |
0.3 | 2.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 5.4 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 0.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 23.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.3 | 1.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 5.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 2.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 4.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 1.9 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 8.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 1.6 | GO:0002177 | manchette(GO:0002177) |
0.3 | 1.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 2.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 1.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 1.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 3.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.7 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.8 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 0.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 1.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.2 | GO:1904949 | ATPase complex(GO:1904949) |
0.2 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 3.1 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 1.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.8 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 5.1 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.6 | GO:0045240 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 3.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 7.8 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 1.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 31.6 | GO:0030424 | axon(GO:0030424) |
0.2 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.6 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.8 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 2.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 2.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 2.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 1.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 1.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 1.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 6.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 5.5 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.6 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.9 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 5.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 6.6 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 3.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 3.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 29.2 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 8.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 1.1 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 2.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 3.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 3.1 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 7.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 2.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.3 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.8 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 2.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.7 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 6.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 1.7 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 1.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.3 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 2.9 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 91.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.1 | GO:0005685 | U1 snRNP(GO:0005685) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.9 | 8.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.8 | 11.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.7 | 8.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.6 | 7.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
2.5 | 7.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.4 | 11.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.0 | 7.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.9 | 16.9 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.9 | 3.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.8 | 5.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.8 | 3.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.7 | 5.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.7 | 6.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.6 | 4.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.6 | 16.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.5 | 6.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.5 | 4.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.5 | 6.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.5 | 7.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.4 | 4.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.4 | 4.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.4 | 4.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.3 | 2.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 9.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.2 | 4.9 | GO:0015265 | urea channel activity(GO:0015265) |
1.2 | 3.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.2 | 5.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.2 | 3.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.1 | 4.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.1 | 9.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.1 | 30.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.1 | 3.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.1 | 3.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.1 | 4.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.1 | 4.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.1 | 3.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.1 | 4.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.1 | 3.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.1 | 5.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.0 | 3.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.0 | 8.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.0 | 2.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.0 | 3.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.0 | 3.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.0 | 4.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.0 | 3.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.0 | 10.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.0 | 4.8 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 2.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.0 | 2.9 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.0 | 7.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.9 | 2.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.9 | 4.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.9 | 3.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.9 | 6.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.9 | 4.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.9 | 7.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.9 | 6.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.9 | 7.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.9 | 3.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.9 | 10.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.9 | 3.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.8 | 3.4 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.8 | 3.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.8 | 4.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.8 | 4.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 2.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.8 | 4.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.8 | 1.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.8 | 4.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.8 | 13.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.8 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.8 | 19.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.8 | 2.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.8 | 1.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.8 | 3.0 | GO:0034618 | arginine binding(GO:0034618) |
0.8 | 3.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.7 | 2.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.7 | 5.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.7 | 2.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.7 | 3.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.7 | 4.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 3.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.7 | 3.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 2.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.7 | 2.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.7 | 9.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.7 | 11.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.7 | 2.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.7 | 2.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.7 | 5.4 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.7 | 2.0 | GO:0008066 | ionotropic glutamate receptor activity(GO:0004970) glutamate receptor activity(GO:0008066) |
0.7 | 25.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.6 | 1.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.6 | 3.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.6 | 4.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.6 | 3.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 1.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 1.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.6 | 13.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 2.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.6 | 4.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.6 | 3.6 | GO:0016594 | glycine binding(GO:0016594) |
0.6 | 3.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 1.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.6 | 1.7 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.6 | 5.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.6 | 2.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.6 | 2.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.6 | 1.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.6 | 2.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.6 | 5.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.6 | 1.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.6 | 1.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.6 | 3.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.5 | 2.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 6.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 5.9 | GO:0031402 | sodium ion binding(GO:0031402) |
0.5 | 1.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.5 | 1.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.5 | 2.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 1.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 8.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.5 | 6.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 5.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.5 | 1.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 2.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 2.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.5 | 13.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 2.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 2.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 2.5 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.5 | 5.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.5 | 6.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.5 | 3.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 2.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.5 | 2.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 2.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 3.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 0.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.5 | 1.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 13.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 2.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 1.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 1.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 0.9 | GO:0043398 | HLH domain binding(GO:0043398) |
0.5 | 8.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 0.5 | GO:0032564 | dATP binding(GO:0032564) |
0.5 | 2.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 0.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 0.4 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.4 | 2.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 2.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 1.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 1.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 1.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 0.4 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.4 | 6.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.4 | 9.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 4.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 5.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 23.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.4 | 1.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 2.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 1.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.4 | 3.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 5.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 1.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 3.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 2.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 2.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 2.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 7.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 5.0 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 2.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 3.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 1.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 2.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.3 | 1.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 1.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 0.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 2.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 0.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 2.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 2.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 0.6 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.3 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 1.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 0.9 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 0.9 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 0.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 0.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 0.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 3.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 0.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 8.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 6.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 0.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 2.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 0.9 | GO:0004802 | transketolase activity(GO:0004802) |
0.3 | 1.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 1.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 0.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 1.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 2.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 3.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 2.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 1.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 4.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 11.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 7.3 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.3 | 0.3 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.3 | 1.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 1.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 0.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 2.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 2.2 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 2.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 2.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 0.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 1.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 4.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 1.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 5.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 1.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.2 | 0.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 2.4 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.2 | 4.7 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 7.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 3.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 0.4 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 2.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 3.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.2 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.2 | 1.5 | GO:0043762 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 1.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 1.9 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 0.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 1.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.2 | 5.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 0.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 2.7 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 5.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 1.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 1.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.5 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 3.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 3.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.2 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 7.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 1.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 2.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.8 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 0.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 2.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 1.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 3.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.8 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.1 | 1.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.3 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 2.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 2.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 2.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 4.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 1.5 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 3.6 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 6.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.8 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 6.1 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 1.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 1.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 2.0 | GO:0015079 | potassium ion transmembrane transporter activity(GO:0015079) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.5 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 1.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 1.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.6 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 1.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.6 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 16.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.4 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 2.4 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 3.0 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 2.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 2.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 3.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 2.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 1.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 2.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 1.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 3.5 | GO:0015297 | antiporter activity(GO:0015297) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.1 | GO:0034903 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 3.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.8 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 2.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 3.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 7.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 1.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.5 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 3.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 1.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 1.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.8 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 1.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 4.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 7.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 1.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 1.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 2.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 1.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.0 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.3 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 9.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 1.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.0 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 6.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 11.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 16.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 8.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 10.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 8.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 13.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 11.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 0.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 1.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 16.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 12.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 1.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 3.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 9.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 4.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 6.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 1.1 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 4.5 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 1.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 5.1 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 8.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 2.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 5.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 2.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 5.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 2.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 16.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 1.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 23.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.5 | 16.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.5 | 17.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
1.2 | 14.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.1 | 8.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.1 | 4.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.1 | 11.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.0 | 9.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.0 | 14.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 3.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.9 | 9.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.8 | 0.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.8 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 32.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 11.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.7 | 8.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.6 | 2.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 7.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 9.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.6 | 4.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 1.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 8.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 13.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 8.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 7.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 15.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.5 | 6.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 7.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 6.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 1.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.5 | 6.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 12.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 8.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.4 | 5.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 4.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 9.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.4 | 4.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 0.8 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.4 | 4.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.4 | 5.8 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.4 | 8.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 6.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 3.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 1.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.4 | 7.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 8.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 4.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.3 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 6.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 3.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 2.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 3.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 4.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 5.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 1.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 3.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 0.8 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
0.2 | 2.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 1.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 4.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 2.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 4.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 0.6 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 1.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 10.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 8.4 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.2 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 2.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 2.1 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.2 | 1.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.2 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 2.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 0.9 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.2 | 3.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.3 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 2.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 1.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 0.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 0.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 8.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 5.8 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 6.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 7.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 1.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 1.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 3.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 2.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 4.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 1.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 1.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 2.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |